APA (7th ed.) Citation

Malhani, A. A., Enani, M. A., Sharif-Askari, F. S., Alghareeb, M. R., Bin-Brikan, R. T., AlShahrani, S. A., . . . Tleyjeh, I. M. (2021). Combination of (interferon beta-1b, lopinavir/ritonavir and ribavirin) versus favipiravir in hospitalized patients with non-critical COVID-19: A cohort study. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Malhani, Areej A., Mushira A. Enani, Fatemeh Saheb Sharif-Askari, Mona R. Alghareeb, Roaa T. Bin-Brikan, Safar A. AlShahrani, Rabih Halwani, and Imad M. Tleyjeh. Combination of (interferon Beta-1b, Lopinavir/ritonavir and Ribavirin) Versus Favipiravir in Hospitalized Patients with Non-critical COVID-19: A Cohort Study. Public Library of Science (PLoS), 2021.

MLA (8th ed.) Citation

Malhani, Areej A., et al. Combination of (interferon Beta-1b, Lopinavir/ritonavir and Ribavirin) Versus Favipiravir in Hospitalized Patients with Non-critical COVID-19: A Cohort Study. Public Library of Science (PLoS), 2021.